Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients - PubMed (original) (raw)
Affiliations
- PMID: 1329780
Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients
R Schandalik et al. Arzneimittelforschung. 1992 Jul.
Abstract
The biliary excretion of silybin, the main active component of silymarin, was evaluated by using a specific HPLC method in 9 cholecystectomy patients with T-tube drainage following single oral doses of silipide (CAS 134499-06-2), a lipophilic silybin-phosphatidylcholine complex (IdB 1016), and of silymarin (120 mg, expressed as silybin equivalents). After intake of silipide, the concentration of silybin in bile reached a peak within 4 h and declined thereafter with a mean time of about 10 h. After administration of silymarin, biliary silybin concentrations were several-fold lower than those observed after intake of silipide. The bile collected after silymarin intake also contained considerable amounts of isosilybin (a silybin isomer) and very low levels of silydianin and silycristin. The amount of silybin recovered in bile in free and conjugated form within 48 h accounted for 11% of the dose after silipide and for 3% of the dose after silymarin. Plasma silybin concentrations, determined in 3 subjects, were several-fold lower than those in bile after intake of silipide and mostly undetectable after intake of silymarin. These data indicate that the bioavailability of silybin is much greater after administration of silipide than after administration of silymarin. This results in increased delivery of the compound to the liver, which represents the target organ for pharmacological action.
Similar articles
- Comparative pharmacokinetics of silipide and silymarin in rats.
Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. Morazzoni P, et al. Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):289-97. doi: 10.1007/BF03188811. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8149949 - Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction.
Schandalik R, Perucca E. Schandalik R, et al. Drugs Exp Clin Res. 1994;20(1):37-42. Drugs Exp Clin Res. 1994. PMID: 7924893 - Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW, Lin LC, Tsai TH. Wu JW, et al. J Ethnopharmacol. 2009 Jan 21;121(2):185-93. doi: 10.1016/j.jep.2008.10.036. Epub 2008 Nov 8. J Ethnopharmacol. 2009. PMID: 19041708 Review.
Cited by
- Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection.
Finnegan D, Tocmo R, Loscher C. Finnegan D, et al. Nutrients. 2023 Jul 28;15(15):3371. doi: 10.3390/nu15153371. Nutrients. 2023. PMID: 37571308 Free PMC article. Review. - Probiotic properties and antimicrobial evaluation of silymarin-enriched Lactobacillus bacteria isolated from traditional curd.
Haghshenas B, Kiani A, Mansoori S, Mohammadi-Noori E, Nami Y. Haghshenas B, et al. Sci Rep. 2023 Jul 5;13(1):10916. doi: 10.1038/s41598-023-37350-3. Sci Rep. 2023. PMID: 37407617 Free PMC article. - Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
Koltai T, Fliegel L. Koltai T, et al. J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X211068826. doi: 10.1177/2515690X211068826. J Evid Based Integr Med. 2022. PMID: 35018864 Free PMC article. Review. - A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals.
Khazaei R, Seidavi A, Bouyeh M. Khazaei R, et al. Vet Med Sci. 2022 Jan;8(1):289-301. doi: 10.1002/vms3.641. Epub 2021 Oct 2. Vet Med Sci. 2022. PMID: 34599793 Free PMC article. Review. - Traditional foods with their constituent's antiviral and immune system modulating properties.
Rahman MM, Mosaddik A, Alam AK. Rahman MM, et al. Heliyon. 2021 Jan;7(1):e05957. doi: 10.1016/j.heliyon.2021.e05957. Epub 2021 Jan 14. Heliyon. 2021. PMID: 33462562 Free PMC article. Review.